Riptide Bioscience signs agreement with National Cancer Institute
Riptide Bioscience has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), a part of the National Institutes of Health in the US.
Source: Hospital Management - Category: Hospital Management Source Type: news
More News: Hospital Management